An Allopurinol-Controlled, Randomized, Double-Dummy, Double-Blind, Parallel Between-Group, Comparative Study of Febuxostat (TMX-67), a Non-Purine-Selective Inhibitor of Xanthine Oxidase, in Patients With Hyperuricemia Including Those With Gout in Japan: Phase 3 Clinical Study.
Kamatani, Naoyuki MD, PhD *; Fujimori, Shin MD, PhD +; Hada, Toshikazu MD, PhD ++; Hosoya, Tatsuo MD, PhD [S]; Kohri, Kenjiro MD, PhD [//]; Nakamura, Toshitaka MD, PhD [P]; Ueda, Takanori MD, PhD #; Yamamoto, Tetsuya MD, PhD **; Yamanaka, Hisashi MD, PhD *; Matsuzawa, Yuji MD, PhD ++
JCR: Journal of Clinical Rheumatology.
17(4) Suppl 2:S13-S18, June 2011.
(Format: HTML, PDF)